Market revenue in 2022 | USD 148.5 million |
Market revenue in 2030 | USD 223.3 million |
Growth rate | 5.2% (CAGR from 2022 to 2030) |
Largest segment | Blood |
Fastest growing segment | Blood |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood, Saliva, Urine, Buccal Cells |
Key market players worldwide | Qiagen NV, PerkinElmer, DBS System, Danaher Corp, Eastern Business Forms, Ahlstrom-Munksjö, Amedes Group, GenTegra, Centogene NV Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to specimen collection cards market will help companies and investors design strategic landscapes.
Blood was the largest segment with a revenue share of 89.02% in 2024. Horizon Databook has segmented the U.S. specimen collection cards market based on blood, saliva, urine, buccal cells covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. specimen collection cards market , including forecasts for subscribers. This country databook contains high-level insights into U.S. specimen collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account